Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Botulinum Toxin Type A has become a pivotal agent in modern dermatology, finding applications that range from the correction of dynamic rhytides to adjunctive procedures in surgical settings.

In the clinical evaluations to date, the dose of botulinum toxin type A used to treat gastroparesis ranged from 80 to 200 units. The pyloric sphincter was divided into equal anatomical quadrants, and ...

Huons Biopharma ships first Hutox batch to China, readies fall distribution Chinese rollout set to start after regulatory ...

For people with idiopathic chronic non-obstructive urinary retention caused by external urethral sphincter dysfunction (also known as Fowler's syndrome in younger women and people with female anatomy, ...

U.S. regulators have issued warnings to 18 websites that were selling fake or unapproved versions of Botox and similar wrinkle-relaxing injections. The UK government on Thursday announced plans to ...

Please provide your email address to receive an email when new articles are posted on . Some botulinum toxin type A injection formulations have a faster onset, whereas others were shown to last longer ...

CHICAGO, IL—The use of botulinum toxin type A in patients undergoing cardiac surgery does not seem to reduce the rate of postoperative atrial fibrillation (AF) overall, according to the phase II NOVA ...